- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Progress in Gene Therapy for Ovarian Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 7, Pages 1930
Publisher
MDPI AG
Online
2018-07-02
DOI
10.3390/ijms19071930
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhanced Chemotherapeutic Efficacy of Paclitaxel Nanoparticles Co-delivered with MicroRNA-7 by Inhibiting Paclitaxel-Induced EGFR/ERK pathway Activation for Ovarian Cancer Therapy
- (2018) Xiaojuan Cui et al. ACS Applied Materials & Interfaces
- The future of mesenchymal stem cell-based therapeutic approaches for cancer – From cells to ghosts
- (2018) Andrea Mohr et al. CANCER LETTERS
- A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma
- (2018) Chanhee Han et al. GYNECOLOGIC ONCOLOGY
- The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
- (2018) Wei-Wei Zhang et al. HUMAN GENE THERAPY
- In Vivo Ovarian Cancer Gene Therapy Using CRISPR-Cas9
- (2018) Zhi-Yao He et al. HUMAN GENE THERAPY
- Screening for Ovarian Cancer
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
- (2018) John Heymach et al. JOURNAL OF CLINICAL ONCOLOGY
- Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevance
- (2018) Aleksandra Klemba et al. Wspolczesna Onkologia-Contemporary Oncology
- Are ovarian cancer stem cells the target for innovative immunotherapy?
- (2018) Liang Wang et al. OncoTargets and Therapy
- Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system
- (2018) Kaijian Ling et al. Journal of Ovarian Research
- Angiogenesis and cancer stem cells: New perspectives on therapy of ovarian cancer
- (2017) Anna Markowska et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study
- (2017) Premal H. Thaker et al. GYNECOLOGIC ONCOLOGY
- Application of chimeric antigen receptor-engineered T cells in ovarian cancer therapy
- (2017) Minghui Zhang et al. Immunotherapy
- Combined Gene Therapy Using AdsVEGFR2 and AdsTie2 With Chemotherapy Reduces the Growth of Human Ovarian Cancer and Formation of Ascites in Mice
- (2017) Laura Tuppurainen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Value of Pathology Review in a Population-based Series of Ovarian Tumors
- (2017) Colin J.R. Stewart et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Ovarian cancer stem cells: still an elusive entity?
- (2017) Michela Lupia et al. Molecular Cancer
- Inhibition of enhancer of zeste homolog 2 increases the expression of p16 and suppresses the proliferation and migration of ovarian carcinoma cells in�vitro and in�vivo
- (2017) Fangfang Lu et al. Oncology Letters
- High grade serous ovarian carcinomas originate in the fallopian tube
- (2017) S. Intidhar Labidi-Galy et al. Nature Communications
- Could ALDH2*2 be the reason for low incidence and mortality of ovarian cancer for East Asia women?
- (2017) Shaomin Yan et al. Oncotarget
- CAR-T cell therapy in ovarian cancer: from the bench to the bedside
- (2017) Xinxin Zhu et al. Oncotarget
- Enhanced antitumor effect of biodegradable cationic heparin-polyethyleneimine nanogels delivering FILIP1L∆C103 gene combined with low-dose cisplatin on ovarian cancer
- (2017) Chuan Xie et al. Oncotarget
- Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model
- (2017) Bernice Nounamo et al. Molecular Therapy-Oncolytics
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- Cancer suicide gene therapy: a patent review
- (2016) Saúl Abenhamar Navarro et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Efficient delivery of Notch1 siRNA to SKOV3 cells by cationic cholesterol derivative-based liposome
- (2016) Yunchun Zhao et al. International Journal of Nanomedicine
- Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene
- (2016) Li Luo et al. International Journal of Nanomedicine
- Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells
- (2016) Emiliano Cocco et al. MOLECULAR CANCER THERAPEUTICS
- Nanoghosts as a Novel Natural Nonviral Gene Delivery Platform Safely Targeting Multiple Cancers
- (2016) Limor Kaneti et al. NANO LETTERS
- Adenovirus-mediated truncated Bid overexpression induced by the Cre/LoxP system promotes the cell apoptosis of CD133+ ovarian cancer stem cells
- (2016) Qifang Long et al. ONCOLOGY REPORTS
- Synergistic suppression effect on tumor growth of ovarian cancer by combining cisplatin with a manganese superoxide dismutase-armed oncolytic adenovirus
- (2016) Shi-Bing Wang et al. OncoTargets and Therapy
- IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice
- (2016) Eric D. Thomas et al. Journal of Ovarian Research
- Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2 /neu or EpCAM as target receptors
- (2016) Jan RH Hanauer et al. Molecular Therapy-Oncolytics
- Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy
- (2016) Catherine Dold et al. Molecular Therapy-Oncolytics
- Ovarian cancer treatment with a tumor-targeting and gene expression-controllable lipoplex
- (2016) Zhi-Yao He et al. Scientific Reports
- Involvement of GRP78 in the Resistance of Ovarian Carcinoma Cells to Paclitaxel
- (2015) Li-Ying Zhang et al. Asian Pacific Journal of Cancer Prevention
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Gene therapy for ovarian cancer using carbonyl reductase 1 DNA with a polyamidoamine dendrimer in mouse models
- (2015) A Kobayashi et al. CANCER GENE THERAPY
- Cancer of the ovary, fallopian tube, and peritoneum
- (2015) Jonathan S. Berek et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Efficient Inhibition of Ovarian Cancer by Gelonin Toxin Gene Delivered by Biodegradable Cationic Heparin-polyethyleneimine Nanogels
- (2015) Yu Bai et al. International Journal of Medical Sciences
- Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer
- (2015) G. Salzano et al. MOLECULAR CANCER THERAPEUTICS
- Effect of the WWOX gene on the regulation of the cell cycle and apoptosis in human ovarian cancer stem cells
- (2015) HONGCHAO YAN et al. Molecular Medicine Reports
- Targeted Microbubbles for Ultrasound Mediated Short Hairpin RNA Plasmid Transfection to Inhibit Survivin Gene Expression and Induce Apoptosis of Ovarian Cancer A2780/DDP Cells
- (2015) Yong Zhang et al. MOLECULAR PHARMACEUTICS
- AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer
- (2015) David Pépin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AAV-mediated persistent bevacizumab therapy suppresses tumor growth of ovarian cancer
- (2014) Yi Xie et al. GYNECOLOGIC ONCOLOGY
- A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG–PEI–cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group study
- (2014) Ronald D. Alvarez et al. GYNECOLOGIC ONCOLOGY
- Ultrasound-assisted siRNA delivery via arginine-grafted bioreducible polymer and microbubbles targeting VEGF for ovarian cancer treatment
- (2014) Stelios Florinas et al. JOURNAL OF CONTROLLED RELEASE
- Silencing of cyclooxygenase-2 inhibits the growth, invasion and migration of ovarian cancer cells
- (2014) YANG LIN et al. Molecular Medicine Reports
- Effects of cyclooxygenase-2 gene silencing on the biological behavior of SKOV3 ovarian cancer cells
- (2014) FENG-JUN GUO et al. Molecular Medicine Reports
- Biological characteristics of Taxol-resistant ovarian cancer cells and reversal of Taxol resistance by adenovirus expressing p53
- (2014) QUN LIU et al. Molecular Medicine Reports
- Multifunctional Disulfide-Based Cationic Dextran Conjugates for Intravenous Gene Delivery Targeting Ovarian Cancer Cells
- (2014) Yanyan Song et al. MOLECULAR PHARMACEUTICS
- Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer
- (2014) Xiaoqian Yang et al. PHARMACEUTICAL RESEARCH
- Inhibitory effects of the ultrasound-targeted microbubble destruction-mediated herpes simplex virus-thymidine kinase/ganciclovir system on ovarian cancer in mice
- (2014) XIAN-LONG ZHOU et al. Experimental and Therapeutic Medicine
- Gene therapy of ovarian cancer using IL-21-secreting human umbilical cord mesenchymal stem cells in nude mice
- (2014) Yunxia Zhang et al. Journal of Ovarian Research
- Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) J. A. Ledermann et al. ANNALS OF ONCOLOGY
- Murine double minute 2 siRNA and wild-type p53 gene therapy enhances sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro and in vivo
- (2013) Junlian Gu et al. CANCER LETTERS
- Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer
- (2013) Jennifer L. Dembinski et al. CYTOTHERAPY
- Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid–poly(ethylene glycol)–chitosan oligosaccharide lactate nanoparticles: For the potential targeted ovarian cancer gene therapy
- (2013) Tony Shing Chau Li et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer
- (2013) Khursheed Anwer et al. GYNECOLOGIC ONCOLOGY
- Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase
- (2013) A.D. Hartkopf et al. GYNECOLOGIC ONCOLOGY
- A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
- (2013) Kenneth H. Kim et al. GYNECOLOGIC ONCOLOGY
- Oncolytic viral therapy with a combination of HF10, a herpes simplex virus type 1 variant and granulocyte-macrophage colony-stimulating factor for murine ovarian cancer
- (2013) Fumi Goshima et al. INTERNATIONAL JOURNAL OF CANCER
- Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites
- (2013) V.A. Jennings et al. INTERNATIONAL JOURNAL OF CANCER
- Staging classification for cancer of the ovary, fallopian tube, and peritoneum
- (2013) Jaime Prat et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Tumor suppressor p16INK4a inhibits cancer cell growth by downregulating eEF1A2 through a direct interaction
- (2013) M.-H. Lee et al. JOURNAL OF CELL SCIENCE
- Folate-linked lipoplexes for short hairpin RNA targeting claudin-3 delivery in ovarian cancer xenografts
- (2013) Zhi-Yao He et al. JOURNAL OF CONTROLLED RELEASE
- Effect of siRNA targeting MTA1 on metastasis malignant phenotype of ovarian cancer A2780 cells
- (2013) Yu-mei Rao et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- A novel plasmid and SonoVue formulation plus ultrasound sonication for effective gene delivery in nude mice
- (2013) Xin-Lu Wang et al. LIFE SCIENCES
- Biodistribution and antitumor effect of Cetuximab-targeted lentivirus
- (2013) Tuulia Huhtala et al. NUCLEAR MEDICINE AND BIOLOGY
- Preclinical Safety, Toxicology, and Biodistribution Study of Adenoviral Gene Therapy with sVEGFR-2 and sVEGFR-3 Combined with Chemotherapy for Ovarian Cancer
- (2013) Laura Tuppurainen et al. Human Gene Therapy Clinical Development
- A Phase I Clinical Trial of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Patients with Recurrent Gynecologic Cancer
- (2012) K. H. Kim et al. CLINICAL CANCER RESEARCH
- Ovarian Cancer
- (2012) JESSICA HUNN et al. CLINICAL OBSTETRICS AND GYNECOLOGY
- Intraperitoneal delivery of nanoparticles for cancer gene therapy
- (2012) Somayeh Hallaj-Nezhadi et al. Future Oncology
- Antiangiogenic gene therapy with soluble VEGF-receptors -1, -2 and -3 together with paclitaxel prolongs survival of mice with human ovarian carcinoma
- (2012) Minna Sopo et al. INTERNATIONAL JOURNAL OF CANCER
- Efficient inhibition of intraperitoneal ovarian cancer growth in nude mice by liposomal delivery of short hairpin RNA against STAT3
- (2012) Qingyuan Jiang et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells
- (2012) LI JIANG et al. Molecular Medicine Reports
- Two-in-one: combined targeted chemo and gene therapy for tumor suppression and prevention of metastases
- (2012) Min Zhang et al. Nanomedicine
- Targeted endostatin-cytosine deaminase fusion gene therapy plus 5-fluorocytosine suppresses ovarian tumor growth
- (2012) Y-P Sher et al. ONCOGENE
- Thymosin β10 Expression Driven by the Human TERT Promoter Induces Ovarian Cancer-Specific Apoptosis through ROS Production
- (2012) Young-Chae Kim et al. PLoS One
- Ovarian Cancer Gene Therapy Using HPV-16 Pseudovirion Carrying the HSV-tk Gene
- (2012) Chien-Fu Hung et al. PLoS One
- Targeted microbubbles for ultrasound mediated gene transfection and apoptosis induction in ovarian cancer cells
- (2012) Shufang Chang et al. ULTRASONICS SONOCHEMISTRY
- In vitro and in vivo growth inhibition of drug-resistant ovarian carcinoma cells using a combination of cisplatin and a TRAIL-encoding retrovirus
- (2012) FANG LI et al. Oncology Letters
- Purine Nucleoside Phosphorylase mediated molecular chemotherapy and conventional chemotherapy: A tangible union against chemoresistant cancer
- (2011) Preetinder P Singh et al. BMC CANCER
- Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer
- (2011) P. E. Vivas-Mejia et al. CLINICAL CANCER RESEARCH
- Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer
- (2011) Daniel T. Rein et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells
- (2011) Ruitao Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells
- (2011) Yang Lin et al. MEDICAL ONCOLOGY
- State-of-the-art gene-based therapies: the road ahead
- (2011) Mark A. Kay NATURE REVIEWS GENETICS
- Efficient inhibition of ovarian cancer by short hairpin RNA targeting claudin-3
- (2011) Xia Zhao ONCOLOGY REPORTS
- Concise Review: Mesenchymal Stem Cell Tumor-Homing: Detection Methods in Disease Model Systems
- (2011) Michaela R. Reagan et al. STEM CELLS
- Chemosensitization of cancer cells by siRNA using targeted nanogel delivery
- (2010) Erin B Dickerson et al. BMC CANCER
- Augmenting Therapy of Ovarian Cancer Efficacy by Secreting IL-21 Human Umbilical Cord Blood Stem Cells in Nude Mice
- (2010) Weihua Hu et al. CELL TRANSPLANTATION
- CD59 Silencing via Retrovirus-Mediated RNA Interference Enhanced Complement-Mediated Cell Damage in Ovary Cancer
- (2010) Xuexiang Shi et al. Cellular & Molecular Immunology
- A Phase I Study of a Tropism-Modified Conditionally Replicative Adenovirus for Recurrent Malignant Gynecologic Diseases
- (2010) K. J. Kimball et al. CLINICAL CANCER RESEARCH
- Nonviral gene delivery to human ovarian cancer cells using arginine-grafted PAMAM dendrimer
- (2010) Soo Hyun Jang et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Adeno-associated virus-mediated delivery of kringle 5 of human plasminogen inhibits orthotopic growth of ovarian cancer
- (2010) T M B Nguyen et al. GENE THERAPY
- Cloning of WWOX gene and its growth-inhibiting effects on ovarian cancer cells
- (2010) Zhoufang Xiong et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF
- (2010) Anniina Koski et al. MOLECULAR THERAPY
- Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor
- (2010) Svetlana Komarova et al. Journal of Ovarian Research
- Concomitant exposure of ovarian cancer cells to docetaxel, CPT-11 or SN-38 and adenovirus-mediated p53 gene therapy
- (2009) Susanna Miettinen et al. ANTI-CANCER DRUGS
- Tumor-directed gene therapy in mice using a composite nonviral gene delivery system consisting of the piggyBac transposon and polyethylenimine
- (2009) Yu Kang et al. BMC CANCER
- Suppression of ovarian cancer growth via systemic administration with liposome-encapsulated adenovirus-encoding endostatin
- (2009) L Yang et al. CANCER GENE THERAPY
- Nanoparticle-Delivered Suicide Gene Therapy Effectively Reduces Ovarian Tumor Burden in Mice
- (2009) Y.-H. Huang et al. CANCER RESEARCH
- Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer
- (2009) K Anwer et al. GENE THERAPY
- Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cytokines in nude mice model
- (2009) Jun Dou et al. IMMUNOBIOLOGY
- The effect of endostatin mediated by human mesenchymal stem cells on ovarian cancer cells in vitro
- (2009) Jing Jiang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Treatment of disseminated ovarian cancer using nonviral interleukin-12 gene therapy delivered intraperitoneally
- (2009) Jason G. Fewell et al. JOURNAL OF GENE MEDICINE
- A novel hTERT promoter-driven E1A therapeutic for ovarian cancer
- (2009) X. Xie et al. MOLECULAR CANCER THERAPEUTICS
- Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis
- (2009) Y.-H. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reversal of the malignant phenotype of ovarian cancer A2780 cells through transfection with wild-type PTEN gene
- (2008) Huijuan Wu et al. CANCER LETTERS
- Antiangiogenic Gene Therapy With Soluble VEGFR-1, -2, and -3 Reduces the Growth of Solid Human Ovarian Carcinoma in Mice
- (2008) Hanna Sallinen et al. MOLECULAR THERAPY
- Efficient Inhibition of Ovarian Cancer Growth and Prolonged Survival by Transfection with a Novel Pro-Apoptotic Gene, hPNAS-4, in a Mouse Model
- (2008) Fan Yang et al. ONCOLOGY
- rAAV/Her-2/neu Loading of Dendritic Cells for a Potent Cellular-Mediated MHC Class I Restricted Immune Response Against Ovarian Cancer
- (2008) Yuefei Yu et al. VIRAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More